The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2

Fiji: an open-source platform for biological-image analysis

Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T., Preibisch, S., Rueden, C., Saalfeld, S., Schmid, B., et al. (2012) · Nature Methods · doi:10.1038/nmeth.2019 · Cited by 66,890

Ultrafast and memory-efficient alignment of short DNA sequences to the human genome.

Langmead, B., Trapnell, C., Pop, M., & Salzberg, S. L. (2009) · Genome Biology · doi:10.1186/gb-2009-10-3-r25 · Cited by 21,849

TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions.

Kim, D., Pertea, G., Trapnell, C., Pimentel, H., Kelley, R., & Salzberg, S. L. (2013) · Genome Biology · doi:10.1186/gb-2013-14-4-r36 · Cited by 12,668

STRING v10: protein–protein interaction networks, integrated over the tree of life

Szklarczyk, D., Franceschini, A., Wyder, S., Forslund, K., Heller, D., Huerta-Cepas, J., Simonovic, M., Roth, A., Santos, A., Tsafou, K. P., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1003 · Cited by 10,436

mTOR Signaling in Growth Control and Disease

Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509

Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool

Chen, E. Y., Tan, C. M., Kou, Y., Duan, Q., Wang, Z., Meirelles, G. V., Clark, N. R., & Ma’ayan, A. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-128 · Cited by 7,814

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex

Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216

Improved vectors and genome-wide libraries for CRISPR screening

Sanjana, N. E., Shalem, O., & Zhang, F. (2014) · Nature Methods · doi:10.1038/nmeth.3047 · Cited by 5,239

In-gel digestion for mass spectrometric characterization of proteins and proteomes

Shevchenko, A., Tomas, H., Havli, J., Olsen, J. V., & Mann, M. (2006) · Nature Protocols · doi:10.1038/nprot.2006.468 · Cited by 4,947

mTOR at the nexus of nutrition, growth, ageing and disease

Liu, G. Y., & Sabatini, D. M. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0199-y · Cited by 2,737

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges

Zou, Z., Tao, T., Li, H., & Zhu, X. M. (2020) · Cell & Bioscience · doi:10.1186/s13578-020-00396-1 · Cited by 951

Regulation and metabolic functions of mTORC1 and mTORC2

Szwed, A., Kim, E., & Jacinto, E. (2021) · Physiological Reviews · doi:10.1152/physrev.00026.2020 · Cited by 855

mTOR: Role in cancer, metastasis and drug resistance

Murugan, A. K. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.07.003 · Cited by 483

The metabolic landscape of RAS-driven cancers from biology to therapy

Mukhopadhyay, S., Vander Heiden, M. G., & McCormick, F. (2021) · Nature Cancer · doi:10.1038/s43018-021-00184-x · Cited by 315

Regulation of mTORC2 Signaling

Fu, W., & Hall, M. N. (2020) · Genes · doi:10.3390/genes11091045 · Cited by 225

The origins and genetic interactions of KRAS mutations are allele- and tissue-specific

Cook, J. H., Melloni, G. E. M., Gulhan, D. C., Park, P. J., & Haigis, K. M. (2021) · Nature Communications · doi:10.1038/s41467-021-22125-z · Cited by 208

Mass spectrometry‐based protein–protein interaction networks for the study of human diseases

Richards, A., Eckhardt, M., & Krogan, N. J. (2021) · Molecular Systems Biology · doi:10.15252/msb.20188792 · Cited by 205

Mapping the proximity interaction network of the Rho-family GTPases reveals signalling pathways and regulatory mechanisms

Bagci, H., Sriskandarajah, N., Robert, A., Boulais, J., Elkholi, I. E., Tran, V., Lin, Z., Thibault, M.-P., Dubé, N., Faubert, D., et al. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0438-7 · Cited by 174

RAS mutations in human cancers: Roles in precision medicine

Murugan, A. K., Grieco, M., & Tsuchida, N. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.06.007 · Cited by 146

The mTORC2 signaling network: targets and cross-talks

Ragupathi, A., Kim, C., & Jacinto, E. (2024) · Biochemical Journal · doi:10.1042/bcj20220325 · Cited by 122

PRMT5-mediated arginine methylation activates AKT kinase to govern tumorigenesis

Yin, S., Liu, L., Brobbey, C., Palanisamy, V., Ball, L. E., Olsen, S. K., Ostrowski, M. C., & Gan, W. (2021) · Nature Communications · doi:10.1038/s41467-021-23833-2 · Cited by 93

Dynamic regulation of RAS and RAS signaling

Kölch, W., Berta, D., & Rosta, E. (2023) · Biochemical Journal · doi:10.1042/bcj20220234 · Cited by 92

Interpretation of cancer mutations using a multiscale map of protein systems

Zheng, F., Kelly, M. R., Ramms, D. J., Heintschel, M. L., Tao, K., Tutuncuoglu, B., Lee, J. J., Ono, K., Foussard, H., Chen, M., et al. (2021) · Science · doi:10.1126/science.abf3067 · Cited by 81

Pleiotropic use of Statins as non-lipid-lowering drugs

Zhang, Q., Dong, J., & Yu, Z. Y. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.42965 · Cited by 78

Splicing Factor SRSF1 Promotes Pancreatitis and KRASG12D-Mediated Pancreatic Cancer

Wan, L., Lin, K., Rahman, M. A., Ishigami, Y., Wang, Z., Jensen, M. A., Wilkinson, J. E., Park, Y., Tuveson, D. A., & Krainer, A. R. (2023) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-1013 · Cited by 72

Expression of mTOR in normal and pathological conditions

Marques-Ramos, A., & Cervantes, R. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01820-z · Cited by 77

In vivo interactome profiling by enzyme‐catalyzed proximity labeling

Xu, Y., Fan, X., & Hu, Y. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00542-3 · Cited by 64

The Ins and Outs of RAS Effector Complexes

Kiel, C., Matallanas, D., & Kölch, W. (2021) · Biomolecules · doi:10.3390/biom11020236 · Cited by 59

To Investigate the Occurrence and Development of Colorectal Cancer Based on the PI3K/AKT/mTOR Signaling Pathway

Zhong, J., Ding, S., Zhang, X., Di, W., Wang, X., Zhang, H., Chen, Y., Zhang, Y., & Hu, Y. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2802037 · Cited by 61

Ceramide Kinase Inhibition Drives Ferroptosis and Sensitivity to Cisplatin in Mutant KRAS Lung Cancer by Dysregulating VDAC-Mediated Mitochondria Function

Vu, N., Kim, M., Stephenson, D., MacKnight, H. P., & Chalfant, C. E. (2022) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-22-0085 · Cited by 53

Oncogenic KRAS is dependent upon an EFR3A-PI4KA signaling axis for potent tumorigenic activity

Adhikari, H., Kattan, W. E., Kumar, S., Zhou, P., Hancock, J. F., & Counter, C. M. (2021) · Nature Communications · doi:10.1038/s41467-021-25523-5 · Cited by 47

Disruption of the Scaffolding Function of mLST8 Selectively Inhibits mTORC2 Assembly and Function and Suppresses mTORC2-Dependent Tumor Growth In Vivo

Hwang, Y., Kim, L. C., Song, W., Edwards, D. N., Cook, R. S., & Chen, J. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3658 · Cited by 54

The role of metabolic ecosystem in cancer progression — metabolic plasticity and mTOR hyperactivity in tumor tissues

Sebestyén, A. R., Dankó, T., Sztankovics, D., Moldvai, D., Raffay, R. E., Cervi, C., Krencz, I., Zsiros, V., Jeney, A., & Petővári, G. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-10006-2 · Cited by 48

The flipside of the TOR coin – TORC2 and plasma membrane homeostasis at a glance

Riggi, M., Kuśmider, B., & Loewith, R. (2020) · Journal of Cell Science · doi:10.1242/jcs.242040 · Cited by 48

Emerging Roles for Mammalian Target of Rapamycin (mTOR) Complexes in Bladder Cancer Progression and Therapy

Huan, J., Grivas, P. D., Birch, J., & Hansel, D. E. (2022) · Cancers · doi:10.3390/cancers14061555 · Cited by 45

Not all RAS mutations are equal: A detailed review of the functional diversity of RAS hot spot mutations

Burge, R. A., & Hobbs, G. A. (2022) · Advances in cancer research · doi:10.1016/bs.acr.2021.07.004 · Cited by 44

20(S)-Protopanaxatriol promotes the binding of P53 and DNA to regulate the antitumor network via multiomic analysis

Wang, Z., Wu, W., Guan, X., Guo, S., Li, C., Niu, R., Gao, J., Jiang, M., Bai, L., Leung, E. L., et al. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.01.017 · Cited by 41

Ras assemblies and signaling at the membrane

Nussinov, R., Tsai, C., & Jang, H. (2020) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2020.01.009 · Cited by 40

Methylglyoxal Scavengers Resensitize KRAS-Mutated Colorectal Tumors to Cetuximab

Bellier, J., Nokin, M.-J., Caprasse, M., Tiamiou, A., Blomme, A., Scheijen, J. L., Koopmansch, B., MacKay, G. M., Chiavarina, B., Costanza, B., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.01.012 · Cited by 38

RAS interaction with Sin1 is dispensable for mTORC2 assembly and activity

Castel, P., Dharmaiah, S., Sale, M. J., Messing, S. A. J., Rizzuto, G. A., Cuevas-Navarro, A., Cheng, A. S., Trnka, M. J., Urisman, A., Esposito, D., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2103261118 · Cited by 39

The Roles of Post-Translational Modifications on mTOR Signaling

Yin, S., Liu, L., & Gan, W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041784 · Cited by 39

Cross-talk between non-coding RNAs and PI3K/AKT/mTOR pathway in colorectal cancer

Moafian, Z., Maghrouni, A., Soltani, A., & Hashemy, S. I. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06458-y · Cited by 37

TOR complex 2 is a master regulator of plasma membrane homeostasis

Thorner, J. W. (2022) · Biochemical Journal · doi:10.1042/bcj20220388 · Cited by 38

Glutamine Metabolism in Both the Oxidative and Reductive Directions Is Triggered in Shrimp Immune Cells (Hemocytes) at the WSSV Genome Replication Stage to Benefit Virus Replication

He, S.-T., Lee, D.-Y., Tung, C.-Y., Li, C.-Y., & Wang, H. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02102 · Cited by 37

Promotion of cancer cell stemness by Ras

Chippalkatti, R., & Abankwa, D. (2021) · Biochemical Society Transactions · doi:10.1042/bst20200964 · Cited by 34

mTOR Signaling Components in Tumor Mechanobiology

Gargalionis, A. N., Papavassiliou, K. A., Basdra, E. K., & Papavassiliou, A. G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031825 · Cited by 36

A novel MTORC2-AKT-ROS axis triggers mitofission and mitophagy-associated execution of colorectal cancer cells upon drug-induced activation of mutant KRAS

Iskandar, K. B., Foo, J., Liew, A. Q. X., Zhu, H., Raman, D., Hirpara, J. L., Leong, Y. Y., Babak, M. V., Kirsanova, A. A., Armand, A., et al. (2024) · Autophagy · doi:10.1080/15548627.2024.2307224 · Cited by 36

Signaling Pathways Involved in Nutrient Sensing Control in Cancer Stem Cells: An Overview

Robles‐Flores, M., Moreno-Londoño, Á. P., & Castañeda‐Patlán, M. C. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.627745 · Cited by 35

Alkaline intracellular pH (pHi) activates AMPK–mTORC2 signaling to promote cell survival during growth factor limitation

Kazyken, D., Lentz, S. I., & Fingar, D. C. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101100 · Cited by 34

Ras, PI3K and mTORC2 – three's a crowd?

Smith, S. F., Collins, S. E., & Charest, P. G. (2020) · Journal of Cell Science · doi:10.1242/jcs.234930 · Cited by 34

Mechanosensitive mTORC2 independently coordinates leading and trailing edge polarity programs during neutrophil migration

Saha, S., Town, J. P., & Weiner, O. D. (2023) · Molecular Biology of the Cell · doi:10.1091/mbc.e22-05-0191 · Cited by 31

Functional and structural insights into RAS effector proteins

Mozzarelli, A. M., Simanshu, D. K., & Castel, P. (2024) · Molecular Cell · doi:10.1016/j.molcel.2024.06.027 · Cited by 33

DNA-PK promotes activation of the survival kinase AKT in response to DNA damage through an mTORC2-ECT2 pathway

Liu, L., Dai, X., Yin, S., Liu, P., Hill, E. G., Wei, W., & Gan, W. (2022) · Science Signaling · doi:10.1126/scisignal.abh2290 · Cited by 29

Oncogenic KRAS engages an RSK1/NF1 pathway to inhibit wild-type RAS signaling in pancreatic cancer

Cheng, D. K., Oni, T. E., Thalappillil, J. S., Park, Y., Ting, H.-C., Alagesan, B., Prasad, N. V., Addison, K., Rivera, K. D., Pappin, D. J., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2016904118 · Cited by 30

Capturing the primordial Kras mutation initiating urethane carcinogenesis

Li, S., MacAlpine, D. M., & Counter, C. M. (2020) · Nature Communications · doi:10.1038/s41467-020-15660-8 · Cited by 28

Oncogenic RAS commandeers amino acid sensing machinery to aberrantly activate mTORC1 in multiple myeloma

Yang, Y., Bolomsky, A., Oellerich, T., Chen, P., Ceribelli, M., Häupl, B., Wright, G. W., Phelan, J. D., Huang, D. W., Lord, J. W., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33142-x · Cited by 29

PTPN2 regulates the activation of KRAS and plays a critical role in proliferation and survival of KRAS-driven cancer cells

Huang, Z., Liu, M., Li, D., Tan, Y., Zhang, R., Xia, Z., Wang, P., Jiao, B., Liu, P., & Ren, R. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.011060 · Cited by 27

Mass Spectrometry-Based Protein Complex Profiling in Time and Space

Zheng, J., Chen, X., Yang, Y., Tan, C. S. H., & Tian, R. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c04332 · Cited by 26

CD146 Regulates Growth Factor-Induced mTORC2 Activity Independent of the PI3K and mTORC1 Pathways

Xu, W., Hua, H., Chiu, Y.-H., Li, G., Zhi, H., Yu, Z., Ren, F., Luo, Y., & Cui, W. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.09.047 · Cited by 32

Signaling pathway dysregulation in breast cancer

Ryspayeva, D., Seyhan, A. A., MacDonald, W., Purcell, C., Roady, T. J., Ghandali, M., Verovkina, N., El‐Deiry, W. S., Taylor, M. S., & Graff, S. L. (2025) · Oncotarget · doi:10.18632/oncotarget.28701 · Cited by 31

Proximity labeling methods for proteomic analysis of membrane proteins

Zafra, F., & Piniella, D. (2022) · Journal of Proteomics · doi:10.1016/j.jprot.2022.104620 · Cited by 24

Silicon-rhodamine-enabled identification for near-infrared light controlled proximity labeling in vitro and in vivo

Wang, W., Guo, H., Yan, X., Pan, X., Wang, X., Rong, Y., Bai, Z., Zhang, L., Wu, Z., Zhao, X., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-63496-x · Cited by 29

Structural insights into Ras regulation by SIN1

Zheng, Y., Ding, L., Meng, X., Potter, M., Kearney, A. L., Zhang, J., Sun, J., James, D. E., Yang, G., & Zhou, C. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2119990119 · Cited by 25

Anti-leukemic effect of menthol, a peppermint compound, on induction of apoptosis and autophagy

Naksawat, M., Norkaew, C., Charoensedtasin, K., Roytrakul, S., & Tanyong, D. I. (2023) · PeerJ · doi:10.7717/peerj.15049 · Cited by 22

Mapping of mTOR drug targets: Featured platforms for anti-cancer drug discovery

Shams, R. S., Ito, Y., & Miyatake, H. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.108012 · Cited by 22

Regulation of GTPase function by autophosphorylation

Johnson, C. W., Seo, H., Terrell, E. M., Yang, M.-H., KleinJan, F., Gebregiworgis, T., Gasmi-Seabrook, G. M. C., Geffken, E. A., Lakhani, J., Song, K., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.02.011 · Cited by 21

KRAS-Driven Tumorigenesis and KRAS-Driven Therapy in Pancreatic Adenocarcinoma

Than, M. T., O’Hara, M. H., Stanger, B. Z., & Reiss, K. A. (2024) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-23-0519 · Cited by 22

mTORC2 regulates ribonucleotide reductase to promote DNA replication and gemcitabine resistance in non-small cell lung cancer

Tian, L., Chen, C., Guo, Y., Zhang, F., Mi, J., Feng, Q., Lin, S., Xi, N., Tian, J., Yu, L., et al. (2021) · Neoplasia · doi:10.1016/j.neo.2021.05.007 · Cited by 21

mTOR Signaling in the Inner Ear as Potential Target to Treat Hearing Loss

Cortada, M., Levano, S., & Bodmer, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126368 · Cited by 21

Reconstruction and analysis of a large-scale binary Ras-effector signaling network

Catozzi, S., Ternet, C., Gourrege, A., Wynne, K. J., Oliviero, G., & Kiel, C. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-022-00823-5 · Cited by 20

Using Drosophila melanogaster to Dissect the Roles of the mTOR Signaling Pathway in Cell Growth

Frappaolo, A., & Giansanti, M. G. (2023) · Cells · doi:10.3390/cells12222622 · Cited by 24

Kallikrein 13 serves as a priming protease during infection by the human coronavirus HKU1

Milewska, A., Falkowski, K., Kulczycka, M., Bielecka, E., Naskalska, A., Mak, P., Lesner, A., Ochman, M., Urlik, M., Diamandis, E. P., et al. (2020) · Science Signaling · doi:10.1126/scisignal.aba9902 · Cited by 30

Afadin couples RAS GTPases to the polarity rheostat Scribble

Goudreault, M., Gagné, V., Jo, C. H., Singh, S., Killoran, R. C., Gingras, A., & Smith, M. J. (2022) · Nature Communications · doi:10.1038/s41467-022-32335-8 · Cited by 17

Flavonoids Targeting the mTOR Signaling Cascades in Cancer: A Potential Crosstalk in Anti‐Breast Cancer Therapy

Hussain, Y., Khan, H. Z., Alam, W., Aschner, M., Abdullah, Alsharif, K. F., & Saso, L. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/4831833 · Cited by 19

Expanding TOR Complex 2 Signaling: Emerging Regulators and New Connections

An, P., Xu, W., Luo, J., & Luo, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.713806 · Cited by 15

Cystine Induced‐mTORC2 Activation through Promoting Sin1 Phosphorylation to Suppress Cancer Cell Ferroptosis

Wang, G., Chen, L., Qin, S., Zheng, Y., Xia, C., Yao, J., Wang, P., & Deng, L. (2022) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202200186 · Cited by 15

RAS GTPase signalling to alternative effector pathways

Singh, S., & Smith, M. J. (2020) · Biochemical Society Transactions · doi:10.1042/bst20200506 · Cited by 15

The RUNX1-ETO target gene RASSF2 suppresses t(8;21) AML development and regulates Rac GTPase signaling

Stoner, S. A., Liu, K. T. H., Andrews, E. T., Liu, M., Arimoto, K., Yan, M., Davis, A. G., Weng, S., Dow, M. T., Su, X., et al. (2020) · Blood Cancer Journal · doi:10.1038/s41408-020-0282-9 · Cited by 15

RICTOR Affects Melanoma Tumorigenesis and Its Resistance to Targeted Therapy

Jebali, A., Battistella, M., Lebbé, C., & Dumaz, N. (2021) · Biomedicines · doi:10.3390/biomedicines9101498 · Cited by 14

Cell cycle control by the insulin-like growth factor signal: at the crossroad between cell growth and mitotic regulation

Scalia, P., Williams, S. J., Fujita‐Yamaguchi, Y., & Giordano, A. (2022) · Cell Cycle · doi:10.1080/15384101.2022.2108117 · Cited by 17

mTORC2 interactome and localization determine aggressiveness of high-grade glioma cells through association with gelsolin

Chantaravisoot, N., Wongkongkathep, P., Kalpongnukul, N., Pacharakullanon, N., Kaewsapsak, P., Ariyachet, C., Loo, J. A., Tamanoi, F., & Pisitkun, T. (2023) · Scientific Reports · doi:10.1038/s41598-023-33872-y · Cited by 14

Regulation of TORC2 Function and Localization in Yeast

Emmerstorfer‐Augustin, A., & Thorner, J. W. (2023) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-011723-030346 · Cited by 15

Unmasking the tumourigenic role of SIN1/MAPKAP1 in the mTOR complex 2

Ezine, E., Lebbé, C., & Dumaz, N. (2023) · Clinical and Translational Medicine · doi:10.1002/ctm2.1464 · Cited by 12

Acquired resistance to molecularly targeted therapies for cancer

Stubbs, N. M., Roady, T. J., Schwermann, M. P., Eteshola, E. O. U., MacDonald, W., Purcell, C., Ryspayeva, D., Verovkina, N., Tajiknia, V., Ghandali, M., et al. (2025) · Cancer Drug Resistance · doi:10.20517/cdr.2024.189 · Cited by 18

Glucose modulates IRF6 transcription factor dimerization to enable epidermal differentiation

Lopez-Pajares, V., Bhaduri, A., Zhao, Y., Gowrishankar, G., Donohue, L. K. H., Guo, M. G., Siprashvili, Z., Miao, W., Nguyen, D. T., Yang, X., et al. (2025) · Cell stem cell · doi:10.1016/j.stem.2025.02.017 · Cited by 20

mTORC2 Is Involved in the Induction of RSK Phosphorylation by Serum or Nutrient Starvation

Chou, P.-C., Rajput, S., Zhao, X., Patel, C., Albaciete, D., Oh, W. J., Queen, H., Patel, N., Su, B., Werlen, G., et al. (2020) · Cells · doi:10.3390/cells9071567 · Cited by 15

Drug targeting opportunities en route to Ras nanoclusters

Pavic, K., Chippalkatti, R., & Abankwa, D. (2022) · Advances in cancer research · doi:10.1016/bs.acr.2021.07.005 · Cited by 13

Proximal Protein Interaction Landscape of RAS Paralogs

Béganton, B., Coyaud, É., Laurent, E. M. N., Mangé, A., Jacquemetton, J., Romancer, M. L., Raught, B., & Solassol, J. (2020) · Cancers · doi:10.3390/cancers12113326 · Cited by 13

Proteomic Mapping of the Interactome of KRAS Mutants Identifies New Features of RAS Signalling Networks and the Mechanism of Action of Sotorasib

Nolan, A. A., Raso, C., Kölch, W., von Kriegsheim, A., Wynne, K. J., & Matallanas, D. (2023) · Cancers · doi:10.3390/cancers15164141 · Cited by 11

Defining bone fide effectors of RAS GTPases

Smith, M. J. (2023) · BioEssays · doi:10.1002/bies.202300088 · Cited by 11

Ras functional proximity proteomics establishes mTORC2 as new direct ras effector

Kovalski, J. R., Shanderson, R. L., & Khavari, P. A. (2019) · Oncotarget · doi:10.18632/oncotarget.27025 · Cited by 13

Claudin-1 is a mediator and therapeutic target in primary sclerosing cholangitis

Zompo, F. D., Crouchet, É., Ostyn, T., Nehme, Z., Messé, M., Jühling, F., Désert, R., Vieira, A. T., Moehlin, J., Nakib, D., et al. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2025.08.005 · Cited by 11

PHLPP2 is a pseudophosphatase that lost activity in the metazoan ancestor

Husremović, T., Meier, V., Piëch, L., Siess, K. M., Antonioli, S., Grishkovskaya, I., Kircheva, N., Angelova, S., Wenzl, K., Brandstätter, A., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2417218122 · Cited by 13

Ras-mediated activation of mTORC2 promotes breast epithelial cell migration and invasion

Collins, S. E., Wiegand, M. E., Werner, A. N., Brown, I. N., Mundo, M. I., Swango, D. J., Mouneimne, G., & Charest, P. G. (2022) · Molecular Biology of the Cell · doi:10.1091/mbc.e22-06-0236 · Cited by 12

CRISPR-mediated reversion of oncogenic KRAS mutation results in increased proliferation and reveals independent roles of Ras and mTORC2 in the migration of A549 lung cancer cells

Werner, A. N., Kumar, A. I., & Charest, P. G. (2023) · Molecular Biology of the Cell · doi:10.1091/mbc.e23-05-0152 · Cited by 12

A Proteomic Approach Identifies Isoform-Specific and Nucleotide-Dependent RAS Interactions

Miller, S. P., Maio, G. E., Zhang, X., Soto, F. S. B., Zhu, J., Ramirez, S. Z., & Lin, H. (2022) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2022.100268 · Cited by 11

Oncogenic mutations of KRAS modulate its turnover by the CUL3/LZTR1 E3 ligase complex

Damianou, A., Liang, Z., Lassen, F. H., Vendrell, I., Vere, G., Hester, S., Charles, P. D., Pinto-Fernández, A., Santos, A., Fischer, R., et al. (2024) · Life Science Alliance · doi:10.26508/lsa.202302245 · Cited by 11

Kallikrein 13: a new player in coronaviral infectionsPreprint

Milewska, A., Falkowski, K., Kalińska, M., Bielecka, E., Naskalska, A., Mak, P., Lesner, A., Ochman, M., Urlik, M., Potempa, J., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.01.971499 · Cited by 9

RAS isoform specific activities are disrupted by disease associated mutations during cell differentiation

Chippalkatti, R., Parisi, B., Kouzi, F., Laurini, C., Fredj, N. B., & Abankwa, D. (2024) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2024.151425 · Cited by 10

mTORC1 and 2 Adrenergic Regulation and Function in Brown Adipose Tissue

Festuccia, W. T. (2024) · Physiology · doi:10.1152/physiol.00023.2024 · Cited by 8

Role of FLCN Phosphorylation in Insulin‐Mediated mTORC1 Activation and Tumorigenesis

Wang, G., Chen, L., Lei, X., Qin, S., Geng, H., Zheng, Y., Xia, C., Yao, J., Meng, T., & Deng, L. (2023) · Advanced Science · doi:10.1002/advs.202206826 · Cited by 7

Regulation of RNA-binding proteins by small biomolecules

Miao, W., Porter, D. F., Lopez-Pajares, V., & Khavari, P. A. (2025) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-025-00914-4 · Cited by 7

Decoding the contextual duality of CD40 functions

Bandyopadhyay, S., Gurjar, D., Saha, B., & Bodhale, N. P. (2023) · Human Immunology · doi:10.1016/j.humimm.2023.08.142 · Cited by 7

MicroRNAs targeted mTOR as therapeutic agents to improve radiotherapy outcome

Taeb, S., Rostamzadeh, D., Amini, S. M., Rahmati, M., Eftekhari, M., Safari, A., & Najafi, M. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03420-3 · Cited by 7

Prion-induced ferroptosis is facilitated by RAC3

Peng, H. F., Pfeiffer, S., Варинський, Б. О., Qiu, M., Srinark, C., Jin, X., Zhang, X., Williams, K., Groveman, B. R., Foliaki, S. T., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-60793-3 · Cited by 7

Identification of novel genes including NAV2 associated with isolated tall stature

Weiß, B., Ott, T., Vick, P., Lui, J. C. K., Roeth, R., Vogel, S., Waldmüller, S., Hoffmann, S., Baron, J., Wit, J. M., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1258313 · Cited by 6

mTORC2: A neglected player in aging regulation

Xu, W., Chen, H., & Xiao, H. (2024) · Journal of Cellular Physiology · doi:10.1002/jcp.31363 · Cited by 7

Regulation of TORC2 function and localization by Rab5 GTPases inSaccharomyces cerevisiae

Locke, M. N., & Thorner, J. W. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1616999 · Cited by 8

A cryptic microdeletion del(12)(p11.21p11.23) within an unbalanced translocation t(7;12)(q21.13;q23.1) implicates new candidate loci for intellectual disability and Kallmann syndrome

Ben‐Mahmoud, A., Kishikawa, S., Gupta, V. R., Leach, N. T., Shen, Y., Moldovan, O., Goel, H., Hopper, B., Ranguin, K., Gruchy, N., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-40037-4 · Cited by 5

Ras functional proximity proteomics establishes mTORC2 as new direct ras effector

Kovalski, J. R., Shanderson, R. L., & Khavari, P. A. (2019) · Oncotarget · doi:10.18632/oncotarget.27025 · Cited by 13

Using BioID to Characterize the RAS Interactome

Adhikari, H., & Counter, C. M. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1190-6_16 · Cited by 4

The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. Kovalski et al.

Khavari, P. A. (2018) · Data Archiving and Networked Services (DANS) · doi:10.17632/kzxnrmh7fc

Proximal Protein Interaction Landscape of RIT2 Neuronal GTPase

White, S. S., Liu, H., Campos, A. R., & Andres, D. (2021) · The FASEB Journal · doi:10.1096/fasebj.2021.35.s1.05423

Direct physical interaction of active Ras with mSIN1 regulates mTORC2 signaling

Lone, M. D., Miyan, J., Asif, M., Malik, S. A., Dubey, P., Singh, V., Singh, K., Mitra, K., Pandey, D., Haq, W., et al. (2019) · BMC Cancer · doi:10.1186/s12885-019-6422-6 · Cited by 25